We detected strong SNX9 expression and co-localization with podocin in ADR-injected mice and samples from human patients with severe glomerular diseases such as IgAN-poor, MN and FSGS, suggesting a pivotal role for SNX9 in podocin endocytosis under pathological conditions. This evidence concerns the gene SNX9 and glomerular disorder.